This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Analysts' Actions: AXP, MS, BLK, USB, CHK

NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS

Abbott Laboratories (AB) numbers raised at Goldman. Shares of ABT now seen reaching $59. Estimates also increased, to match the company's new guidance. Neutral rating.

Financial firm Access National (ANCX) is upgraded to buy at TheStreet Ratings.

Agrium (AGM) upgraded at JP Morgan to Overweight. Agriculture fundamentals are robust.

American Express (AXP - Get Report) removed from Top Picks at Citigroup. Shares of AXP now seen reaching $58. Estimates also lowered on Europe softness. Maintain Buy rating.

American Express estimates cut at Goldman through 2013. Company is releasing fewer reserves. Buy rating and $56 price target.

Amphenol (APH) estimates, target lowered at Citigroup. Shares of APH now seen reaching $51. Estimates also lowered as defense spending trends remain clouded due to Washington. Buy rating.

Amphenol estimates, target cut at Credit Suisse. Shares of APH now seen reaching $49. Estimates also reduced, given weaker end-market demand. Outperform rating.

Amphenol estimates, target lowered at UBS. Shares of APH now seen reaching $46. Estimates also lowered as 4Q outlook impacted by Telecom/IT Datacom. Neutral rating.

Apollo (APOL) estimates, target increased at Citigroup. Shares of APOL now seen reaching $50. Estimates also raised on positive outlook and regulatory concerns waning. Neutral rating.

Apollo estimates, target raised at Credit Suisse. Shares of APOL now seen reaching $52. Estimates also increased, given higher growth in starts. Outperform rating.

BlackRock (BLK - Get Report) estimates increased at Citigroup through 2012. NAVs partially offset by lower ST flows. Maintain $180 price target and Buy rating.

BlackRock estimates, target reduced at Credit Suisse. Shares of BLK now seen reaching $194. Estimates also cut, given lower net flows. Outperform rating.

Celestica (CLS) downgraded at Ticonderoga from Buy to Neutral. Slower end-market demand could hurt growth. Company is also highly leveraged to Research in Motion.

Cheesecake Factory (CAKE) numbers cut at Credit Suisse. Shares of CAKE now seen reaching $30. Estimates also reduced, as the company is struggling to leverage higher sales. Neutral rating.

Chesapeake Energy rated new Buy at Sterne Agee. CHK was initiated with a Buy rating. $40 price target. Company is cutting debt and liquids business should drive growth.

Cognizant (CTSH) downgraded at Goldman to Neutral. Valuation call.

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
ABT $47.44 0.91%
BLK $369.94 0.22%
AXP $81.15 0.64%
CHK $15.92 2.78%
CSX $33.88 -1.05%

Markets

DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs